Publication:
A nationwide experience with the off label use of interleukin 1 targeting treatment in familial mediterranean fever patients

Simple item page
dc.contributor.authorAkar, Servet
dc.contributor.authorÇetin, Pınar
dc.contributor.authorKalyoncu, Umut
dc.contributor.authorKaradağ, Ömer
dc.contributor.authorSarı, İsmail
dc.contributor.authorÇınar, Muhammed
dc.contributor.authorYılmaz, Sedat
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorKısacık, Bünyamin
dc.contributor.authorErden, Abdülsamet
dc.contributor.authorBalkarlı, Ayşe
dc.contributor.authorKüçükşahin, Orhan
dc.contributor.authorÖner, Sibel Yılmaz
dc.contributor.authorŞenel, Soner
dc.contributor.authorTufan, Abdurrahman
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorÖksüz, Mustafa Ferhat
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorBayndır, Özün
dc.contributor.authorKeser, Gökhan
dc.contributor.authorAksu, Kenan
dc.contributor.authorOmma, Ahmet
dc.contributor.authorKaşifoğlu, Timuçin
dc.contributor.authorÜnal, Ali Uğur
dc.contributor.authorYıldız, Fatih
dc.contributor.authorBalcı, Mehmet Ali
dc.contributor.authorYavuz, Şule
dc.contributor.authorErten, Şükran
dc.contributor.authorÖzgen, Metin
dc.contributor.authorSayarıoğlu, Mehmet
dc.contributor.authorDoğru, Atalay
dc.contributor.authorÇetin, Gözde Yıldırım
dc.contributor.authorAlibaz-Öner, Fatma
dc.contributor.authorTezcan, Mehmet Engin
dc.contributor.authorPamuk, Ömer Nuri
dc.contributor.authorÖnen, Fatos
dc.contributor.buuauthorÖksüz, Mustafa Ferhat
dc.contributor.buuauthorPEHLİVAN, YAVUZ
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.
dc.contributor.researcheridJXF-7598-2024
dc.contributor.researcheridAAG-8227-2021
dc.date.accessioned2024-08-14T06:36:58Z
dc.date.available2024-08-14T06:36:58Z
dc.date.issued2016-10-01
dc.descriptionBu çalışma, 11-16, Kasım 2016 tarihlerinde Washington[Amerika]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Health-Professionals (ACR/ARHP) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Coll Rheumatol
dc.description.sponsorshipAssoc Rheumatol Hlth Profess
dc.identifier.issn2326-5191
dc.identifier.issueSupplement 10
dc.identifier.urihttps://hdl.handle.net/11452/44013
dc.identifier.volume68
dc.identifier.wos000417143401346
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalArthritis & Rheumatology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRheumatology
dc.titleA nationwide experience with the off label use of interleukin 1 targeting treatment in familial mediterranean fever patients
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication0075f2ae-ae8a-4690-bd46-128775e8efac
relation.isAuthorOfPublication.latestForDiscovery0075f2ae-ae8a-4690-bd46-128775e8efac

Files

Collections

Yeni Yayınlar